上皮性鈣黏附蛋白活性蛋白
Active E-cadherin
CDHE; CD324; CDH1; Arc1; ECAD; CDH-E; E-CAD; LCAM; UVO; Cadherin 1 Type 1; Uvomorulin; E-Cadherin; Calcium-Dependent Adhesion Protein, Epithelial; Liver Cell Adhesion Molecule
- 編號APA017Hu61
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點4.0
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 2227 ¥ 5568 ¥ 11136 ¥ 33408 ¥ 83520
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
活性實驗
E-Cadherin, also known as Uvomorulin in the mouse and rat, is a 120?kDa member of the Cadherin family of cell surface glycoproteins that mediate cell adhesion. Human E-Cadherin shares 81%?amino acid sequence identity with the rat and mouse proteins. It is a single-pass transmembrane protein that mediates calcium-dependent epithelial cell adhesion. As E-cadherin has the function of cell adhesion, we measure the activity of recombinant human E-cadherin by the ability of the immobilized protein to support the adhesion of MCF7 human breast cancer cells. When 5 x 104?cells/well are added to different concentrations of recombinat human E-cadherin coated plates, cells will adhere after 2?hour incubation at 37 ℃. The adhesion of MCF7 after 2?hour incubation at 37 ℃ observed by inverted microscope was shown in Figure 1. Cell adherent was in a dose dependent manner, the result was shown in Figure 2, the EC50 was 0.19 ug/ml.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APA017Hu62 | 上皮性鈣黏附蛋白活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA017Hu01 | 上皮性鈣黏附蛋白重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA017Hu61 | 上皮性鈣黏附蛋白活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA017Hu62 | 上皮性鈣黏附蛋白真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA017Hu61 | 上皮性鈣黏附蛋白真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA017Hu01 | 上皮性鈣黏附蛋白多克隆抗體 | WB; IHC; ICC; IP. |
| PAA017Hu02 | 上皮性鈣黏附蛋白多克隆抗體 | WB; IHC; ICC; IP. |
| LAA017Hu71 | 上皮性鈣黏附蛋白多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA017Hu81 | 上皮性鈣黏附蛋白多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAA017Hu23 | 上皮性鈣黏附蛋白單克隆抗體 | WB; IHC; ICC; IP. |
| MAA017Hu22 | 上皮性鈣黏附蛋白單克隆抗體 | WB; IHC; ICC; IP. |
| MAA017Hu21 | 上皮性鈣黏附蛋白單克隆抗體 | WB; IHC; ICC; IP. |
| MAA017Hu24 | 上皮性鈣黏附蛋白單克隆抗體 | WB; IHC; ICC; IP. |
| SEA017Hu | 上皮性鈣黏附蛋白檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA017Hu | 上皮性鈣黏附蛋白檢測試劑盒(化學發光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA017Hu | 上皮性鈣黏附蛋白等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| J Periodontal Res. | Novel method for proliferation of oral keratinocyte stem cells [Pubmed: 24329011] |
| The Journal of?Gene?Medicine | Modulation of the Dual‐Faced Effects of miR‐141 with Chitosan/miR‐141 Nanoplexes in Breast Cancer Cells [Pubmed: 31389101] |
| Cell Adhesion & Migration | BST2 regulates interferon gamma-dependent decrease in invasion of HTR-8/SVneo cells via STAT1 and AKT signaling pathways and expression of E-cadherin [Pubmed: 31957537] |
| DOKLADY BIOCHEMISTRY AND BIOPHYSICS | Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy … [Pubmed: 32342301] |
| Non-POU Domain-Containing Octamer-Binding (NONO) Protein Stability Regulated by PIN1 is Crucial for Breast Cancer Tumorigenicity Via the MAPK/β?… [] |
